Literature DB >> 10834961

Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci.

F Garcia-Garrote1, E Cercenado, E Bouza.   

Abstract

We evaluated the new automated VITEK 2 system (bioMérieux) for the identification and antimicrobial susceptibility testing of enterococci. The results obtained with the VITEK 2 system were compared to those obtained by reference methods: standard identification by the scheme of Facklam and Sahm [R. R. Facklam and D. F. Sahm, p. 308-314, in P. R. Murray et al., ed., Manual of Clinical Microbiology, 6th ed., 1995] and with the API 20 STREP system and, for antimicrobial susceptibility testing, broth microdilution and agar dilution methods by the procedures of the National Committee for Clinical Laboratory Standards. The presence of vanA and vanB genes was determined by PCR. A total of 150 clinical isolates were studied, corresponding to 60 Enterococcus faecalis, 55 Enterococcus faecium, 26 Enterococcus gallinarum, 5 Enterococcus avium, 2 Enterococcus durans, and 2 Enterococcus raffinosus isolates. Among those isolates, 131 (87%) were correctly identified to the species level with the VITEK 2 system. Approximately half of the misidentifications were for E. faecium with low-level resistance to vancomycin, identified as E. gallinarum or E. casseliflavus; however, a motility test solved the discrepancies and increased the agreement to 94%. Among the strains studied, 66% were vancomycin resistant (57 VanA, 16 VanB, and 26 VanC strains), 23% were ampicillin resistant (MICs, >/=16 microgram/ml), 31% were high-level gentamicin resistant, and 45% were high-level streptomycin resistant. Percentages of agreement for susceptibility and resistance to ampicillin, vancomycin, and teicoplanin and for high-level gentamicin resistance and high-level streptomycin resistance were 93, 95, 97, 97, and 96%, respectively. The accuracy of identification and antimicrobial susceptibility testing of enterococci with the VITEK 2 system, together with the significant reduction in handling time, will have a positive impact on the work flow of the clinical microbiology laboratory.

Entities:  

Mesh:

Year:  2000        PMID: 10834961      PMCID: PMC86739          DOI: 10.1128/JCM.38.6.2108-2111.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

2.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

3.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Automated identification of gram-positive bacteria.

Authors:  K L Ruoff; M J Ferraro; M E Jerz; J Kissling
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

6.  High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.

Authors:  G M Eliopoulos; C Wennersten; S Zighelboim-Daum; E Reiszner; D Goldmann; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

7.  Genes involved in the regulation of beta-lactamase production in enterococci and staphylococci.

Authors:  K K Zscheck; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.

Authors:  B E Murray; B Mederski-Samaroj
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species.

Authors:  R R Facklam; D L Rhoden; P B Smith
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

10.  Comparative evaluation of the API 20S and AutoMicrobic gram-positive identification systems for non-beta-hemolytic streptococci and aerococci.

Authors:  R Facklam; G S Bosley; D Rhoden; A R Franklin; N Weaver; R Schulman
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

View more
  25 in total

1.  Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae.

Authors:  P J Gavin; J R Warren; A A Obias; S M Collins; L R Peterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

2.  Use of a genus- and species-specific multiplex PCR for identification of enterococci.

Authors:  Charlene R Jackson; Paula J Fedorka-Cray; John B Barrett
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system.

Authors:  Marina de Cueto; Esther Ceballos; Luis Martinez-Martinez; Evelio J Perea; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

Authors:  J-L Donay; D Mathieu; P Fernandes; C Prégermain; P Bruel; A Wargnier; I Casin; F X Weill; P H Lagrange; J L Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Validation of VITEK 2 version 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci.

Authors:  Marianne Abele-Horn; Leif Hommers; René Trabold; Matthias Frosch
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

6.  Rapid identification of clinically relevant Enterococcus species by fluorescence in situ hybridization.

Authors:  Nele Wellinghausen; Melanie Bartel; Andreas Essig; Sven Poppert
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

7.  Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory.

Authors:  Guido Funke; Pascale Funke-Kissling
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

8.  Antibiotic resistance and virulence factors among clinical and food enterococci isolated in Slovakia.

Authors:  H Drahovská; L Slobodníková; D Kocíncová; M Seman; R Konceková; J Trupl; J Turna
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

9.  Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems.

Authors:  U Eigner; A Schmid; U Wild; D Bertsch; A-M Fahr
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

10.  Rapid detection of methicillin resistance in coagulase-negative Staphylococci with the VITEK 2 system.

Authors:  Matthias A Horstkotte; Johannes K-M Knobloch; Holger Rohde; Sabine Dobinsky; Dietrich Mack
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.